NFKB1 and cancer: Nevertheless, studies in recent years show that cancer cells can gradually adapt to the ROS overload environment by increasing antioxidant capacity and activating NF-κB and nuclear factor E2-related factor 2 (NRF2), the master regulator of antioxidant response, to induce tumor progression and chemoresistance.